Search

everythinglearnresearchcommunity

for

Search:↓

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

Medicines for enlarged prostate may raise the risk of breast growth and tenderness but not breast cancer.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Some common medications can harm male fertility, but many effects can be reversed.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Dutasteride and finasteride don't raise erectile dysfunction risk.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Hormones, especially androgens, play a key role in causing acne, and treatments like hormone control pills and hormone-blocking medications can help.

Dutasteride reduces DHT more effectively than finasteride.

Plant-based remedies may treat hair loss by reducing inflammation and improving insulin resistance.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Taking 5α-reductase inhibitors does not significantly increase the risk of breast cancer in men.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Taking 5-Alpha Reductase Inhibitors before bladder removal surgery might make high-grade bladder tumors less aggressive.

Using 5-alpha-reductase inhibitors, drugs for prostate issues and hair loss, may lead to eye abnormalities in men.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.

Using 5-alpha reductase inhibitors may increase the risk of mild depression.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Natural herbal compounds might treat certain medical conditions by reducing DHT levels, but more research is needed to confirm their effectiveness and safety.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Pueraria mirifica extract may help treat benign prostatic hyperplasia.

5 alpha reductase inhibitors can cause sexual, cognitive, and muscle side effects, and may slightly increase aggressive cancer risk.

New compounds show promise as nonsteroidal treatments for hair loss.